169 related articles for article (PubMed ID: 12077549)
1. Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisolone.
Nijsten T; Meuleman L; Schroyens W; Lambert J
Dermatology; 2002; 204(4):365-7. PubMed ID: 12077549
[TBL] [Abstract][Full Text] [Related]
2. Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide.
Foti C; Antelmi A; Mazzocca A; Saverio Vella F; Romita P; Pugliese S; Lomazzo D; Portincasa P; Palasciano G
Eur J Dermatol; 2012; 22(6):799-800. PubMed ID: 23137713
[No Abstract] [Full Text] [Related]
3. Adverse effects of thalidomide administration in patients with neoplastic diseases.
Dimopoulos MA; Eleutherakis-Papaiakovou V
Am J Med; 2004 Oct; 117(7):508-15. PubMed ID: 15464708
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide-induced hemorrhagic rash in a patient with myelofibrosis and delta-granule storage pool disease.
Taj A; Abbi K; Skeel RT
Am J Ther; 2015; 22(1):e6-7. PubMed ID: 24105355
[TBL] [Abstract][Full Text] [Related]
5. Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma.
Sviggum HP; Davis MD; Rajkumar SV; Dispenzieri A
Arch Dermatol; 2006 Oct; 142(10):1298-302. PubMed ID: 17043184
[TBL] [Abstract][Full Text] [Related]
6. Desensitization to thalidomide in a patient with multiple myeloma.
Nucera E; Schiavino D; Hohaus S; Leone G; Buonomo A; Lombardo C; Patriarca G
Clin Lymphoma Myeloma; 2008 Jun; 8(3):176-8. PubMed ID: 18650182
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide-induced neuropathy.
Crawford CL
Mayo Clin Proc; 2002 Dec; 77(12):1395; author reply 1395. PubMed ID: 12479531
[No Abstract] [Full Text] [Related]
8. Role of thalidomide in the treatment of patients with multiple myeloma.
Morgan GJ; Davies FE
Crit Rev Oncol Hematol; 2013 Oct; 88 Suppl 1():S14-22. PubMed ID: 23827438
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan.
Wu SY; Yeh YM; Chen YP; Su WC; Chen TY
Ann Hematol; 2012 Nov; 91(11):1773-8. PubMed ID: 22706703
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide treatment for immunoglobulin D multiple myeloma in a patient on chronic hemodialysis.
Hayashi T; Yamaguchi I; Saitoh H; Takagi M; Nonaka Y; Nomura T
Intern Med; 2003 Jul; 42(7):605-8. PubMed ID: 12879955
[TBL] [Abstract][Full Text] [Related]
11. [Thalidomide therapy of cutaneous lupus erythematosus].
Bohmeyer J; Achenbach A; Westenberger M; Stadler R
Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
[TBL] [Abstract][Full Text] [Related]
12. Palliative oncology: thalidomide.
Prommer EE
Am J Hosp Palliat Care; 2010 May; 27(3):198-204. PubMed ID: 19843880
[TBL] [Abstract][Full Text] [Related]
13. [Thalidomide with or without dexamethasone for refractory multiple myeloma].
Boulin M; Blanchet F; Isambert N; Solary E; Solier S; Collin B; Pernot C; Durnet-Archeray MJ
Therapie; 2002; 57(6):524-9. PubMed ID: 12666259
[TBL] [Abstract][Full Text] [Related]
14. Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma.
Trojan A; Chasse E; Gay B; Pichert G; Taverna C
Ann Oncol; 2003 Mar; 14(3):501-2. PubMed ID: 12598363
[No Abstract] [Full Text] [Related]
15. A strategy of 'treating through' a prasugrel-induced rash.
Yang DC; Feldman DN; Kim LK; Minutello RM; Bergman G; Wong SC; Swaminathan RV
Int J Cardiol; 2013 Oct; 168(4):4381-2. PubMed ID: 23706323
[No Abstract] [Full Text] [Related]
16. Thalidomide in multiple myeloma: state of art.
Tosi P; Cavo M
Haematologica; 2002 Mar; 87(3):233-4. PubMed ID: 11869932
[No Abstract] [Full Text] [Related]
17. Thalidomide-induced organizing pneumonia.
Feaver AA; McCune DE; Mysliwiec AG; Mysliwiec V
South Med J; 2006 Nov; 99(11):1292-4. PubMed ID: 17195429
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide in multiple myeloma.
Rajkumar SV
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 13):11-6. PubMed ID: 11204667
[TBL] [Abstract][Full Text] [Related]
19. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
[TBL] [Abstract][Full Text] [Related]
20. [Suspected itchy rash secondary to lenalidomide].
Escudero-Vilaplana V; Osorio Prendes S; Sanjurjo Sáez M
Farm Hosp; 2014 Nov; 38(6):495-6. PubMed ID: 25542665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
